Profit machinery upgraded while volume still arriving

CVS Health Corporation (CVS) — this company's answers

The model's full reasoning — Q1 2018 call → NOWe need to answer YES or NO based on the transcript. The question asks: Does management convey that the company has ALREADY ACHIEVED A STRUCTURAL IMPROVEMENT IN HOW MUCH IT KEEPS FROM EACH UNIT OF BUSINESS — through changes the company itself made that are now visible in the recent period's actual results — AND that business volume is SIMULTANEOUSLY GROWING onto that improved structure, so each arriving increment converts to profit at the new, better rate with most of that arriving volume still ahead of the reported results? We need to check both halves: (1) realized step-up in per-unit economics, and (2) volume arriving now and early with most still ahead. From the transcript, management discusses various initiatives. For example, Dave Denton mentions enterprise streamlining efforts, like the eligibility improvement that reduced rejections, leading to cost savings. He says: "We are continuing to make significant progress in our enterprise streamlining efforts and we are already benefiting from enhancements that we've made." That suggests realized improvements. Also, they talk about gross margin improvements, but note that Retail/Long-Term Care gross margin contracted due to reimbursement pressure. However, overall enterprise gross margin improved slightly due to segment mix. But the question is about per-unit economics: meaningfully more per sale, unit, customer, or transaction. They mention improvements in purchasing through Red Oak Sourcing, and also the eligibility rejections reduction. But is that a structural improvement? They also mention that they are generating $475 million in gross benefits this year from streamlining, and expect $700 million annually once complete. That suggests ongoing, but some already realized. Now, volume growth: They increased revenue guidance for Retail/Long-Term Care due to stronger prescription growth. They say: "We are seeing a greater benefit from the broader relationships we established last year with payers as well as from our expanded participation as a preferred pharmacy in various Medicare Part D networks." And they increased same store scripts growth guidance. So volume is growing. And they say most of that arriving volume still ahead? They talk about 2019 selling season, but that's future. For the current year, they have increased guidance, so some volume is already flowing, but they also expect more.

← Back to the full CVS analysis